rituximab
ANHL0221
Phase 2 mab completed
Quick answer
rituximab for Lymphoproliferative Disorder is a Phase 2 program (mab) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Children's Hospital of Fudan University
- Indication
- Lymphoproliferative Disorder
- Phase
- Phase 2
- Modality
- mab
- Status
- completed